Associations of long-term nitrogen dioxide exposure with a wide spectrum of diseases: a prospective cohort study of 0·5 million Chinese adults.
Xia X. et al, (2024), Lancet Public Health, 9, e1047 - e1058
Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults.
Mazidi M. et al, (2024), Eur J Epidemiol
Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels.
Iona A. et al, (2024), Commun Biol, 7
Predictive value of 8-year blood pressure measures in intracerebral haemorrhage risk over 5 years.
Zhang Y. et al, (2024), Eur J Prev Cardiol, 31, 1702 - 1710
Measured and genetically predicted protein levels and cardiovascular diseases in UK Biobank and China Kadoorie Biobank.
Lind L. et al, (2024), Nat Cardiovasc Res
Milk intake, lactase non-persistence and type 2 diabetes risk in Chinese adults.
Kakkoura MG. et al, (2024), Nat Metab
Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations.
Argentieri MA. et al, (2024), Nat Med, 30, 2450 - 2460
Associations of polygenic risk scores with risks of stroke and its subtypes in Chinese.
Yang S. et al, (2024), Stroke Vasc Neurol, 9, 399 - 406
The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk.
Fry H. et al, (2024), Int J Mol Sci, 25
One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study.
Sun Z. et al, (2024), Lancet Reg Health West Pac, 49
Causal relevance of different blood pressure traits on risk of cardiovascular diseases: GWAS and Mendelian randomisation in 100,000 Chinese adults.
Pozarickij A. et al, (2024), Nat Commun, 15
Genetically determined blood pressure, antihypertensive drug classes, and frailty: A Mendelian randomization study.
Zhuang Z. et al, (2024), Aging Cell, 23
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.
Holmes MV. et al, (2024), Eur J Prev Cardiol, 31, 1015 - 1025
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
Yao P. et al, (2024), Diabetes Care, 47, 1012 - 1019
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319
Lifetime and 10-year risks of cardiovascular mortality in relation to risk factors in middle and old age: 50-year follow-up of the Whitehall study of London Civil Servants.
Clarke R. et al, (2024), Public Health, 230, 73 - 80
Association between health insurance cost-sharing and choice of hospital tier for cardiovascular diseases in China: a prospective cohort study.
Levy M. et al, (2024), Lancet Reg Health West Pac, 45
Elevated blood remnant cholesterol and triglycerides are causally related to the risks of cardiometabolic multimorbidity.
Zhao Y. et al, (2024), Nat Commun, 15
Iron Status and Risk of Heart Disease, Stroke, and Diabetes: A Mendelian Randomization Study in European Adults.
Liu Y. et al, (2024), J Am Heart Assoc, 13